These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11186685)

  • 1. [Prostaplant treatment of benign prostatic hyperplasia].
    Medvedev AA; Siniakova LA; Zaĭtsev AV
    Urologiia; 2000; (4):13-5. PubMed ID: 11186685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sabal serrulata extract (Strogen forte) in the treatment of symptomatic benign prostatic hyperplasia.
    Kondás J; Philipp V; Diószeghy G
    Int Urol Nephrol; 1996; 28(6):767-72. PubMed ID: 9089044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo.
    Weisser H; Behnke B; Helpap B; Bach D; Krieg M
    Eur Urol; 1997; 31(1):97-101. PubMed ID: 9032543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of benign prostatic hyperplasia with phytosterols.
    Carbin BE; Larsson B; Lindahl O
    Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The results of long-term permixon treatment in patients with symptoms of lower urinary tracts dysfunction due to benign prostatic hyperplasia].
    Pytel' IuA; Lopatkin NA; Gorilovskiĭ LM; Vinarov AZ; Sivkov AV; Medvedev AA
    Urologiia; 2004; (2):3-7. PubMed ID: 15114742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia.
    Dutkiewicz S
    Int Urol Nephrol; 1996; 28(1):49-53. PubMed ID: 8738619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sabal serrulata extract in the management of symptoms of prostatic hypertrophy].
    Kondás J; Philipp V; Diószeghy G
    Orv Hetil; 1997 Feb; 138(7):419-21. PubMed ID: 9091843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients].
    Vahlensieck W; Völp A; Lubos W; Kuntze M
    Fortschr Med; 1993 Jun; 111(18):323-6. PubMed ID: 7689525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year.
    Romics I; Schmitz H; Frang D
    Int Urol Nephrol; 1993; 25(6):565-9. PubMed ID: 7513678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia.
    Weisser H; Tunn S; Behnke B; Krieg M
    Prostate; 1996 May; 28(5):300-6. PubMed ID: 8610056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial].
    Lopatkin NA; Sivkov AV; Medvedev AA; Walter K; Schlefke S; Avdeĭchuk IuI; Golubev GV; Mel'nik KP; Elenberger NA; Engelman U
    Urologiia; 2006; (2):12, 14-9. PubMed ID: 16708583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined sabal and urtica extract vs. finasteride in benign prostatic hyperplasia (Alken stages I to II). Comment on the contribution by J. Sokeland and J. Albrech].
    Bartsch G; Dreikom K; Schöntöger PS
    Urologe A; 1998 Jan; 37(1):83-5. PubMed ID: 9540190
    [No Abstract]   [Full Text] [Related]  

  • 15. [The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia].
    Aliaev IuG; Vinarov AZ; Demidko IuL; Spivak LG
    Urologiia; 2013; (4):32-6. PubMed ID: 24159762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current trends in the management of BPH (benign prostatic hypertrophy). Decongestion with Sabalextract IDS 89].
    Urologe A; 1995 Jan; 34(1 Suppl):1-4. PubMed ID: 9131098
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.
    Carraro JC; Raynaud JP; Koch G; Chisholm GD; Di Silverio F; Teillac P; Da Silva FC; Cauquil J; Chopin DK; Hamdy FC; Hanus M; Hauri D; Kalinteris A; Marencak J; Perier A; Perrin P
    Prostate; 1996 Oct; 29(4):231-40; discussion 241-2. PubMed ID: 8876706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [5-alpha-reductase inhibitors in benign prostatic hyperplasia].
    Panchev P; Neĭkov K
    Khirurgiia (Sofiia); 1997; 50(1):41-3. PubMed ID: 9379618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.